Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK and Safety of Pantoprazole in Adolescents with GERD
NCT00367614Phase 3Completed
- Sponsor
- Pfizer
- Start
- Jan 2007
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of pantoprazole in gastroesophageal reflux disease (GERD), sponsored by Pfizer. Started Jan 2007; status: completed.
02
Drugs
pantoprazole
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on NCT00367614.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00367614.